Unlocked | Minister called to de-haze budget math on cuts to veterans’ medical cannabis reimbursement. By @LeftHandStu #cdnpoli https://t.co/b04T5L0W6l

Will Canada lead or lag as the international market opens up for medical cannabis? https://t.co/BUZlG82llA

Today, we released our FY26 Q1 financial results, reinforcing our continued leadership in the global cannabis industry. For the complete press release and financial disclosers, visit here: https://t.co/iD57Oha5xo

We’re excited to welcome Rick Savone, SVP of Global Gov’t Relations at Aurora Cannabis, as a keynote speaker at #ACannabis! In “Be Careful What You Wish For,” he’ll dive into how legalisation policies are shaping the industry's future. Register at https://t.co/MPRJbVy9JI

Today, we released our FY25Q4 & Full Fiscal 2025 results, showcasing our continued leadership in the global cannabis industry. For the complete press release and financial disclosers, visit here: https://t.co/s68S2LH7fy

Introducing one of our Summit speakers, Rick Savone, with @Aurora_MMJ.

Today, we released our Q3 Fiscal 2025 results, showcasing our continued leadership in the cannabis industry. For the complete press release and financial disclosers, visit here: https://t.co/mTSKSvpFt1

Complexity, cost, and inefficiency—these are just a few of the challenges licensed producers face with the current excise stamp system. But there’s a better way. Watch this video to learn more:

C3's 2025 Excise Survey results are in, and they are staggering. The need for reform has never been more clear – we need to adjust excise taxation now. Register for the Canadian Cannabis Leadership Summit to join the conversation: https://t.co/zS7xmuFWsQ

Something must change for Canadian cannabis to move forward. C3 invites you to an afternoon of insightful discussion about the key challenges facing the industry. Reserve your spot at the Canadian Cannabis Leadership Summit on Oct 1:

C3 is pleased to announce Tamara Lovi as the new Chair of our Board of Directors. Lovi, who has been a member of the Board for 2 years, brings a wealth of experience and leadership to the role. Read the release:

Excited to share our Q1 Fiscal 2025 results! Highlights: Revenue: +12% YoY to $83.4M Global Medical: Record $47.2M (+13% YoY) Bevo Revenue: $23.1M (+16% YoY) International Sales: +$5.6M Cash: $182M, debt-free EBITDA: +87% to $4.9M Read more: https://t.co/2kQ33JjcGk

C3, Global Affairs Canada disappointed with Israel’s preliminary report

It's time to fix what’s broken. The excise tax must be lowered to give producers a fair shot at making legalization a true success. Read more @nationalpost: Trudeau’s signature pot legalization is failing on all fronts #ExciseTaxReform #CannabisIndustry https://t.co/GNdbqyGn78

Today we released our Q4 FY24 Results: - Record annual Adjusted EBITDA of $12.8M - Quarterly net revenue up 5% YoY to $67.4M - Global medical cannabis revenue grew 20% YoY to $45.6M - Ended FY24 with ~$180M cash, debt-free 🔗 Full update: https://t.co/kmrUQohf5R

We're thrilled to share that our first shipment of medical cannabis has reached the New Zealand market! This marks a significant milestone in our mission of #OpeningTheWorldToCannabis. Read more about this in our press release: [ https://t.co/3FKSduuuVO]

This year's federal budget overlooks crucial reforms in the cannabis sector's tax & regulatory framework, despite clear evidence from the Finance Committee, Competition Bureau and Cannabis Act Review that the industry faces significant financial stress and needs urgent change.

Do you remember when you joined X? I do! #MyXAnniversary

Story from @sol_israel in @MJBizDaily on possible excise tax reform in the federal budget. Features some unfortunately pessimistic comments from yours truly. https://t.co/wT6tAAUB2o

Thrilled to Congratulate Paul McCarthy on Becoming President of @Cannabis_Canada! His leadership will drive positive growth and innovation in the industry. Join us in celebrating! #Cannabis #Leadership #Congratulations